These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7609554)

  • 41. Management of pulmonary arterial hypertension associated with congenital heart disease.
    Togănel R; Benedek I; Suteu C; Blesneac C
    Rom J Intern Med; 2007; 45(3):229-34. PubMed ID: 18333354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary Hypertension in Congenital Heart Disease: Beyond Eisenmenger Syndrome.
    Krieger EV; Leary PJ; Opotowsky AR
    Cardiol Clin; 2015 Nov; 33(4):599-609, ix. PubMed ID: 26471823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pulmonary hypertension associated with congenital heart disease].
    Beghetti M
    Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S49-59; quiz 13S157, 13S159. PubMed ID: 17057631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary hypertension in congenital heart disease.
    Raja SG; Basu D
    Nurs Stand; 2005 Aug 24-30; 19(50):41-9. PubMed ID: 16138617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Apoptotic dysregulation in pulmonary hypertension due to congenital heart disease].
    Lévy M; Bonnet D; Vouhé PR
    Arch Pediatr; 2008 Jun; 15(5):698-701. PubMed ID: 18582719
    [No Abstract]   [Full Text] [Related]  

  • 46. Influence of pulmonary blood pressure and flow on endothelin-1 production in humans.
    Ishikawa S; Miyauchi T; Ueno H; Ushinohama H; Sagawa K; Fusazaki N; Sunagawa H; Honda S; Sakai S; Yamaguchi I
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S429-33. PubMed ID: 8587435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The clinico-pathophysiologic basis for rheopulmonogram changes in congenital heart defects with increased pulmonary blood flow].
    Korotkov AA; Pushkar' IuT; Elizarova NA; Tal'pis BL; Shpil'kin VM
    Kardiologiia; 1972 Aug; 12(8):78-86. PubMed ID: 4642644
    [No Abstract]   [Full Text] [Related]  

  • 48. Importance of adhesion molecules for children with congenital heart disease.
    Yıldırım A; Karaağaç AT; Güzelmeriç F; Çine N; Öner NC
    Cardiol Young; 2013 Feb; 23(1):35-40. PubMed ID: 22717098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow.
    Petrossian E; Parry AJ; Reddy VM; Akkersdijk GP; McMullan DM; Thompson L; Hendricks-Munoz KD; Hallak H; Hanley FL; Fineman JR
    J Thorac Cardiovasc Surg; 1999 Feb; 117(2):314-23. PubMed ID: 9918974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Definition and Management of Segmental Pulmonary Hypertension.
    Dimopoulos K; Diller GP; Opotowsky AR; D'Alto M; Gu H; Giannakoulas G; Budts W; Broberg CS; Veldtman G; Swan L; Beghetti M; Gatzoulis MA
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29973393
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pulmonary hypertension--hemodynamic and clinical examples of some congenital heart defect].
    Keck EW
    Med Klin; 1966 Mar; 61(9):325-30. PubMed ID: 5986157
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pediatric pulmonary hypertension and pulmonary arterial hypertension secondary to congenital heart diseases].
    Olguntürk R
    Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():50-6. PubMed ID: 20819767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Problems of pulmonary hypertension in children with congenital cardiac defects.
    Rabinovitch M
    Chest; 1988 Mar; 93(3 Suppl):119S-126S. PubMed ID: 3277814
    [No Abstract]   [Full Text] [Related]  

  • 55. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pulmonary arterial hypertension in congenital cardiopathies].
    Picchio FM; Rapezzi C; Bonvicini M
    Torace; 1979 Mar; 22(1):72-83. PubMed ID: 400055
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pharmacologic tests for evaluation of the state of the pulmonary vessels in patients with congenital heart defects and severe pulmonary hypertension].
    Burakovskiĭ VI; Bukharin VA; Plotnikova LR; Faĭnberg MA
    Kardiologiia; 1971; 11(4):25-33. PubMed ID: 4999544
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pulmonary hypertension in congenital heart disease].
    Schulze-Neick I
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S322-4. PubMed ID: 17139597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Studies on hemodynamic changes in 110 patients with pulmonary hypertension].
    Hu XD; Yu XZ; Ruan YM; Mao JW; Cai RS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982; 4(2):109-13. PubMed ID: 6216005
    [No Abstract]   [Full Text] [Related]  

  • 60. Preoperative pulmonary hemodynamics and assessment of operability: is there a pulmonary vascular resistance that precludes cardiac operation?
    Giglia TM; Humpl T
    Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S57-69. PubMed ID: 20216166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.